|
1
|
Bhupathiraju SN and Hu FB: Epidemiology of
obesity and diabetes and their cardiovascular complications. Circ
Res. 118:1723–1735. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
NCD Risk Factor Collaboration (NCD-RisC).
Trends in adult body-mass index in 200 countries from 1975 to 2014:
A pooled analysis of 1698 population-based measurement studies with
19·2 million participants. Lancet. 387:1377–1396. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bell GI and Polonsky KS: Diabetes mellitus
and genetically programmed defects in beta-cell function. Nature.
414:788–791. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Blüher M: Obesity: Global epidemiology and
pathogenesis. Nat Rev Endocrinol. 15:288–298. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Debédat J, Amouyal C, Aron-Wisnewsky J and
Clément K: Impact of bariatric surgery on type 2 diabetes:
Contribution of inflammation and gut microbiome? Semin
Immunopathol. 41:461–475. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Puzziferri N, Roshek TB III, Mayo HG,
Gallagher R, Belle SH and Livingston EH: Long-term follow-up after
bariatric surgery: A systematic review. JAMA. 312:934–942.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Schauer PR, Bhatt DL, Kirwan JP, Wolski K,
Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE,
Nissen SE, et al: Bariatric surgery versus intensive medical
therapy for diabetes-5-year outcomes. N Engl J Med. 376:641–651.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Albaugh VL, Sharma G, Tu C and Aminian A:
Clinical significance of diabetes control before metabolic surgery.
Surg Obes Relat Dis. 17:1271–1278. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hofsø D, Fatima F, Borgeraas H, Birkeland
KI, Gulseth HL, Hertel JK, Johnson LK, Lindberg M, Nordstrand N,
Cvancarova Småstuen M, et al: Gastric bypass versus sleeve
gastrectomy in patients with type 2 diabetes (Oseberg): A
single-centre, triple-blind, randomised controlled trial. Lancet
Diabetes Endocrinol. 7:912–924. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Angelini G, Castagneto Gissey L, Del Corpo
G, Giordano C, Cerbelli B, Severino A, Manco M, Basso N, Birkenfeld
AL, Bornstein SR, et al: New insight into the mechanisms of ectopic
fat deposition improvement after bariatric surgery. Sci Rep.
9(17315)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Eickhoff H: Central modulation of energy
homeostasis and cognitive performance after bariatric surgery. Adv
Neurobiol. 19:213–236. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Manning S and Batterham RL: The role of
gut hormone peptide YY in energy and glucose homeostasis: Twelve
years on. Annu Rev Physiol. 76:585–608. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pucci A and Batterham RL: Mechanisms
underlying the weight loss effects of RYGB and SG: Similar, yet
different. J Endocrinol Invest. 42:117–128. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vegiopoulos A, Rohm M and Herzig S:
Adipose tissue: Between the extremes. EMBO J. 36:1999–2017.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Unamuno X, Gómez-Ambrosi J, Rodríguez A,
Becerril S, Frühbeck G and Catalán V: Adipokine dysregulation and
adipose tissue inflammation in human obesity. Eur J Clin Invest.
48(e12997)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Otero M, Lago R, Lago F, Casanueva FF,
Dieguez C, Gómez-Reino JJ and Gualillo O: Leptin, from fat to
inflammation: Old questions and new insights. FEBS Lett.
579:295–301. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dohmen J, Praktiknjo M, Rudeloff A,
Uschner FE, Klein S, Plamper A, Matthaei H, Rheinwalt KP, Wehner S,
Kalff JC, et al: Impact of sleeve gastrectomy and dietary change on
metabolic and hepatic function in an obesity rat model-experimental
research. Int J Surg. 75:139–147. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bužga M, Zavadilová V, Holéczy P, Švagera
Z, Švorc P, Foltys A and Zonča P: Dietary intake and ghrelin and
leptin changes after sleeve gastrectomy. Wideochir Inne Tech
Maloinwazyjne. 9:554–561. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Farey JE, Preda TC, Fisher OM,
Levert-Mignon AJ, Stewart RL, Karsten E, Herbert BR, Swarbrick MM
and Lord RV: Effect of laparoscopic sleeve gastrectomy on fasting
gastrointestinal, pancreatic, and adipose-derived hormones and on
non-esterified fatty acids. Obes Surg. 27:399–407. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Catalioto RM, Maggi CA and Giuliani S:
Chemically distinct HDAC inhibitors prevent adipose conversion of
subcutaneous human white preadipocytes at an early stage of the
differentiation program. Exp Cell Res. 315:3267–3280.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Palhinha L, Liechocki S, Hottz ED, Pereira
JA, de Almeida CJ, Moraes-Vieira PM, Bozza PT and Maya-Monteiro CM:
Leptin induces proadipogenic and proinflammatory signaling in
adipocytes. Front Endocrinol (Lausanne). 10(841)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang EE, Chapeau E, Hagihara K and Feng
GS: Neuronal Shp2 tyrosine phosphatase controls energy balance and
metabolism. Proc Natl Acad Sci USA. 101:16064–16069.
2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
do Carmo JM, da Silva AA, Ebaady SE,
Sessums PO, Abraham RS, Elmquist JK, Lowell BB and Hall JE: Shp2
signaling in POMC neurons is important for leptin's actions on
blood pressure, energy balance, and glucose regulation. Am J
Physiol Regul Integr Comp Physiol. 307:R1438–R1447. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Feng GS: Shp2 as a therapeutic target for
leptin resistance and obesity. Expert Opin Ther Targets.
10:135–142. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
He Z, Zhang SS, Meng Q, Li S, Zhu HH,
Raquil MA, Alderson N, Zhang H, Wu J, Rui L, et al: Shp2 controls
female body weight and energy balance by integrating leptin and
estrogen signals. Mol Cell Biol. 32:1867–1878. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tao J, Zheng L, Meng M, Li Y and Lu Z:
Shp2 suppresses the adipogenic differentiation of preadipocyte
3T3-L1 cells at an early stage. Cell Death Discov.
2(16051)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Durand J, Lampron A, Mazzuco TL, Chapman A
and Bourdeau I: Characterization of differential gene expression in
adrenocortical tumors harboring beta-catenin (CTNNB1) mutations. J
Clin Endocrinol Metab. 96:E1206–E1211. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wu L, Zhou Z, Han S, Chen J, Liu Z, Zhang
X, Yuan W, Ji J and Shu X: PLAGL2 promotes epithelial-mesenchymal
transition and mediates colorectal cancer metastasis via
β-catenin-dependent regulation of ZEB1. Br J Cancer. 122:578–589.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Shen Y, Liu Y, Zheng SQ, Han J, Pei EL, Li
ZH, Xie XY, Li ZQ and Luo M: Effects of left gastric artery
ligation versus sleeve gastrectomy on obesity-induced adipose
tissue macrophage infiltration and inflammation in diet-induced
obese rats. Med Sci Monit. 25:6719–6726. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang X, Zhu C, Gao J, Mei F, Yin J, Bu L,
Cheng X, Sheng C and Qu S: Gender difference in the relationship
between serum uric acid reduction and improvement in body fat
distribution after laparoscopic sleeve gastrectomy in Chinese obese
patients: A 6-month follow-up. Lipids Health Dis.
17(288)2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Church C, Horowitz M and Rodeheffer M: WAT
is a functional adipocyte? Adipocyte. 1:38–45. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ghaben AL and Scherer PE: Adipogenesis and
metabolic health. Nat Rev Mol Cell Biol. 20:242–258.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Schauer PR, Kashyap SR, Wolski K,
Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE
and Bhatt DL: Bariatric surgery versus intensive medical therapy in
obese patients with diabetes. N Engl J Med. 366:1567–1576.
2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Feng Y, Zhong C, Niu J, Zhang L, Zhao Y,
Wang W, Hu Z, Wang H, He P, Ning Q, et al: Effects of sleeve
gastrectomy on lipid and energy metabolism in ZDF rats via PI3K/AKT
pathway. Am J Transl Res. 10:3713–3722. 2018.PubMed/NCBI
|
|
36
|
Myers MG, Cowley MA and Münzberg H:
Mechanisms of leptin action and leptin resistance. Annu Rev
Physiol. 70:537–556. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Friedman JM and Halaas JL: Leptin and the
regulation of body weight in mammals. Nature. 395:763–770.
1998.PubMed/NCBI View
Article : Google Scholar
|
|
38
|
Myers MG Jr, Leibel RL, Seeley RJ and
Schwartz MW: Obesity and leptin resistance: Distinguishing cause
from effect. Trends Endocrinol Metab. 21:643–651. 2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhao S, Zhu Y, Schultz RD, Li N, He Z,
Zhang Z, Caron A, Zhu Q, Sun K, Xiong W, et al: Partial leptin
reduction as an insulin sensitization and weight loss strategy.
Cell Metab. 30:706–719.e6. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Carpenter LR, Farruggella TJ, Symes A,
Karow ML, Yancopoulos GD and Stahl N: Enhancing leptin response by
preventing SH2-containing phosphatase 2 interaction with Ob
receptor. Proc Natl Acad Sci USA. 95:6061–6066. 1998.PubMed/NCBI View Article : Google Scholar
|
|
41
|
He Z, Zhu HH, Bauler TJ, Wang J, Ciaraldi
T, Alderson N, Li S, Raquil MA, Ji K, Wang S, et al: Nonreceptor
tyrosine phosphatase Shp2 promotes adipogenesis through inhibition
of p38 MAP kinase. Proc Natl Acad Sci USA. 110:E79–E88.
2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bettaieb A, Matsuo K, Matsuo I, Nagata N,
Chahed S, Liu S and Haj FG: Adipose-specific deletion of Src
homology phosphatase 2 does not significantly alter systemic
glucose homeostasis. Metabolism. 60:1193–1201. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Moseti D, Regassa A and Kim WK: Molecular
regulation of adipogenesis and potential anti-adipogenic bioactive
molecules. Int J Mol Sci. 17(124)2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Huang WQ, Lin Q, Zhuang X, Cai LL, Ruan
RS, Lu ZX and Tzeng CM: Structure, function, and pathogenesis of
SHP2 in developmental disorders and tumorigenesis. Curr Cancer Drug
Targets. 14:567–588. 2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Feng GS: Shp-2 tyrosine phosphatase:
Signaling one cell or many. Exp Cell Res. 253:47–54.
1999.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Gan L, Liu Z, Cao W, Zhang Z and Sun C:
FABP4 reversed the regulation of leptin on mitochondrial fatty acid
oxidation in mice adipocytes. Sci Rep. 5(13588)2015.PubMed/NCBI View Article : Google Scholar
|
